Edition:
United States

Oncternal Therapeutics Inc (ONCT.PH)

ONCT.PH on Philadelphia Stock Exchange

4.73USD
31 Jul 2019
Change (% chg)

-- (--)
Prev Close
$4.73
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
780
52-wk High
$25.50
52-wk Low
$0.77

About

Oncternal Therapeutics, Inc., formerly GTX, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of product candidates for the treatment of cancers. Its pipeline includes cirmtuzumab, TK-216 and chimeric antigen receptor T-cell (CAR-T). Its cirmtuzumab product candidate is an... (more)
No analyst recommendations are available for .

Overall

Beta: 1.55
Market Cap(Mil.): $131.52
Shares Outstanding(Mil.): 16.06
Dividend: --
Yield (%): --

Financials

  ONCT.PH Industry Sector
P/E (TTM): -- 27.97 32.67
EPS (TTM): -1.71 -- --
ROI: -196.34 6.82 14.48
ROE: -196.34 10.86 15.78
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates